Long-term treatment in rheumatoid arthritis: do biological and targeted-synthetic DMARDs increase the risk of malignancy?

Fagni F, Simon D (2022)

Publication Type: Journal article, Editorial

Publication year: 2022

Journal

Rheumatology Oxford University Press

Book Volume: 61

Pages Range: 1758-1759

Journal Issue: 5

DOI: 10.1093/rheumatology/keab750

Authors with CRIS profile

Filippo Fagni Department of Medicine 3 – Rheumatology and Immunology David Simon Department of Medicine 3 – Rheumatology and Immunology

How to cite

APA:

Fagni, F., & Simon, D. (2022). Long-term treatment in rheumatoid arthritis: do biological and targeted-synthetic DMARDs increase the risk of malignancy? Rheumatology, 61(5), 1758-1759. https://doi.org/10.1093/rheumatology/keab750

MLA:

Fagni, Filippo, and David Simon. "Long-term treatment in rheumatoid arthritis: do biological and targeted-synthetic DMARDs increase the risk of malignancy?" Rheumatology 61.5 (2022): 1758-1759.

BibTeX: Download